(Q36440224)

14 August 2017

1 reference

title

Atypical antipsychotics in the management of delirium: a review of the empirical literature (English)

1 reference

14 August 2017

1 reference

Soenke Boettger

1

1 reference

14 August 2017

William Breitbart

series ordinal

2

1 reference

14 August 2017

publication date

1 September 2005

1 reference

Palliative and Supportive Care

14 August 2017

published in

1 reference

14 August 2017

volume

3

1 reference

14 August 2017

issue

3

1 reference

14 August 2017

page(s)

227-237

1 reference

Atypical antipsychotics and risk of cerebrovascular accidents.

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

An open pilot trial of olanzapine for delirium in the Korean population

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

Antipsychotics and dopamine transporter gene polymorphisms in delirium patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

Science is revolutionizing our view of addiction--and what to do about it.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

A symptom rating scale for delirium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

Update on the neuropathogenesis of delirium

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

Diphenhydramine-induced delirium in elderly hospitalized patients with mild dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

A survey on the drug therapy for delirium

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

Treatment for delirium with risperidone: results of a prospective open trial with 10 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

Olanzapine vs haloperidol: treating delirium in a critical care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

A pilot trial of quetiapine for the treatment of patients with delirium

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

The prognostic significance of subsyndromal delirium in elderly medical inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

21 January 2018

Epidemiology of delirium

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

Delirium in the terminally ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

The Memorial Delirium Assessment Scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

The duration of delirium in medical and postoperative patients referred for psychiatric consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

Regional selectivity of neuroleptic drugs: An argument for site specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

Altered cerebral blood flow and glucose metabolism in patients with liver disease and minimal encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

Side effects of atypical antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

Efficacy of risperidone in treating the hyperactive symptoms of delirium

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

Intravenous ziprasidone for treatment of delirium in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

Delirium (acute confusional states).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

Regional cerebral blood flow in delirium patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

Serotonergic basis of antipsychotic drug effects in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

Ziprasidone treatment of delirium

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

Donepezil improves symptoms of delirium in dementia: implications for future research

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

Neurochemistry and delirium

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

Modifying effects of histamine on circadian rhythms and neuronal excitability

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

The role of atypical antipsychotics in the treatment of delirium

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

A double-blind trial of risperidone and haloperidol for the treatment of delirium

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

Treatment of Delirium With Quetiapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

Assessment scales in delirium

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

Successful treatment of nonanticholinergic delirium with a cholinesterase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

Pharmacology of atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

Efficacy of neuroleptics for hypoactive delirium

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

Treatment of delirium in older adults with quetiapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

Olanzapine in the treatment of delirium

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

7 January 2021

Olanzapine. A review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

7 January 2021

In vivo olanzapine occupancy of muscarinic acetylcholine receptors in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

7 January 2021

A prospective, open-label, flexible-dose study of quetiapine in the treatment of delirium.

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

7 January 2021

The central cholinergic system profile of olanzapine compared with placebo in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

7 January 2021

The occurrence and duration of symptoms in elderly patients with delirium

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

7 January 2021

Delirium in hospitalized older patients

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

7 January 2021

Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

7 January 2021

Validation of the Delirium Rating Scale-revised-98: comparison with the delirium rating scale and the cognitive test for delirium

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

7 January 2021

Delirium: a subcortical phenomenon?

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

7 January 2021

Risperidone in the treatment of patients with delirium.

1 reference

https://api.crossref.org/works/10.1017%2FS1478951505050352

7 January 2021

10.1017/S1478951505050352

Identifiers

DOI

1 reference

14 August 2017

1 reference